AMGEN Trademark

Trademark Overview

On Wednesday, October 19, 2005, a trademark application was filed for AMGEN with the United States Patent and Trademark Office. The USPTO has given the AMGEN trademark a serial number of 78736482. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, March 25, 2021. This trademark is owned by Amgen Inc.. The AMGEN trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceuticals; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; pharmaceuticals for stimulating the growth of platelets and platelet precursor cells; erythropoiesis stimulating protein; pharmaceuticals for stimulating white blood cell production; pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia; pharmaceuticals for treating human immune diseases and conditions; pharmaceutical preparations for the treatment of bone disease; and pre-filled syringes containing pharmaceutical preparations for treatment of the aforementioned diseases and disorders and complications associated therewith
amgen

General Information

Serial Number78736482
Word MarkAMGEN
Filing DateWednesday, October 19, 2005
Status800 - REGISTERED AND RENEWED
Status DateThursday, March 25, 2021
Registration Number3921146
Registration DateTuesday, February 15, 2011
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2006

Trademark Statements

Goods and ServicesHouse mark for a full line of pharmaceuticals; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; pharmaceuticals for stimulating the growth of platelets and platelet precursor cells; erythropoiesis stimulating protein; pharmaceuticals for stimulating white blood cell production; pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia; pharmaceuticals for treating human immune diseases and conditions; pharmaceutical preparations for the treatment of bone disease; and pre-filled syringes containing pharmaceutical preparations for treatment of the aforementioned diseases and disorders and complications associated therewith

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 25, 2005
Primary Code005
First Use Anywhere DateSaturday, March 31, 1984
First Use In Commerce DateSaturday, March 31, 1984

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Friday, June 9, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 25, 2005NEW APPLICATION ENTERED
Sunday, April 23, 2006ASSIGNED TO EXAMINER
Monday, May 1, 2006NON-FINAL ACTION WRITTEN
Monday, May 1, 2006NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 23, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, May 23, 2006EXAMINER'S AMENDMENT ENTERED
Wednesday, May 24, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2006ASSIGNED TO LIE
Thursday, October 25, 2007SOU EXTENSION 2 FILED
Friday, November 9, 2007SOU EXTENSION 2 GRANTED
Wednesday, July 26, 2006NOTICE OF PUBLICATION
Tuesday, August 15, 2006PUBLISHED FOR OPPOSITION
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 7, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 1, 2007SOU TEAS EXTENSION RECEIVED
Tuesday, May 1, 2007SOU EXTENSION 1 FILED
Monday, August 6, 2007SOU EXTENSION 1 GRANTED
Thursday, October 25, 2007SOU TEAS EXTENSION RECEIVED
Tuesday, April 21, 2009SOU EXTENSION 5 FILED
Wednesday, April 16, 2008SOU TEAS EXTENSION RECEIVED
Wednesday, April 16, 2008SOU EXTENSION 3 FILED
Wednesday, April 23, 2008SOU EXTENSION 3 GRANTED
Wednesday, November 5, 2008SOU TEAS EXTENSION RECEIVED
Wednesday, November 5, 2008SOU EXTENSION 4 FILED
Thursday, November 6, 2008SOU EXTENSION 4 GRANTED
Thursday, November 6, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 21, 2009SOU TEAS EXTENSION RECEIVED
Thursday, April 23, 2009SOU EXTENSION 5 GRANTED
Thursday, May 13, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 6, 2009TEAS STATEMENT OF USE RECEIVED
Friday, November 6, 2009USE AMENDMENT FILED
Thursday, November 19, 2009STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 10, 2009SU - NON-FINAL ACTION - WRITTEN
Thursday, December 10, 2009NON-FINAL ACTION E-MAILED
Thursday, December 10, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 13, 2010SU - NON-FINAL ACTION - WRITTEN
Thursday, May 13, 2010NON-FINAL ACTION E-MAILED
Monday, January 30, 2017TEAS SECTION 8 & 15 RECEIVED
Friday, November 12, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 12, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 13, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 15, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 10, 2011ASSIGNED TO LIE
Monday, January 10, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, January 11, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 15, 2011REGISTERED-PRINCIPAL REGISTER
Monday, February 15, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, February 15, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, March 29, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 29, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 29, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 25, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 25, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, December 14, 2020TEAS SECTION 8 & 9 RECEIVED
Thursday, March 25, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, April 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 25, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 25, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 25, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

amgen pharmaceuticals preparations treatment pharmaceutical diseases stimulating therewith associated disorders complications